This compound is primarily utilized in the field of medical research and drug development, particularly in the study of cancer and inflammatory diseases. It functions by simultaneously inhibiting JAK (Janus kinase) and HDAC (histone deacetylase) enzymes, which are critical in regulating cell signaling and gene expression. By targeting these pathways, it shows potential in suppressing the growth of cancer cells and modulating immune responses. Researchers are exploring its efficacy in treating hematologic malignancies, autoimmune disorders, and other conditions where JAK and HDAC pathways are dysregulated. Its dual-action mechanism makes it a promising candidate for combination therapies and overcoming drug resistance in certain cancers.